Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiation therapy for rectal cancer].

Dae Yong Kim1, Kyung Hae Jung

  • 1Center for Colorectal Cancer, National Cancer Center, Goyang, Korea. radiopia@ncc.re.kr

The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|April 25, 2006
PubMed
Summary

Preoperative chemoradiotherapy (CRT) offers improved outcomes for locally advanced rectal cancer compared to surgery alone. This approach enhances local control and sphincter preservation while reducing treatment toxicities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.

Breast cancer (Tokyo, Japan)·2026
Same author

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial.

Nature cancer·2026
Same author

Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer.

Journal of breast cancer·2026
Same author

Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy.

Korean journal of radiology·2026
Same author

Therapeutic Insights and Immune Pathway Connections Revealed by Core Symptom Gene Network Analysis in Ankylosing Spondylitis.

Current issues in molecular biology·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Context:

  • Standard treatment for locally advanced rectal cancer (stages II-III) involves surgery combined with chemoradiotherapy (CRT).
  • Recent evidence suggests preoperative CRT may offer advantages over postoperative CRT.
  • Accurate staging through diagnostic imaging is crucial for treatment planning.

Purpose:

  • To evaluate the efficacy and safety of preoperative chemoradiotherapy (CRT) versus postoperative CRT for locally advanced rectal cancer.
  • To compare local control, sphincter preservation, toxicity, and overall survival between preoperative and postoperative CRT.
  • To highlight the importance of optimizing treatment parameters for preoperative CRT.

Summary:

  • A large prospective randomized study with long-term follow-up demonstrated that preoperative CRT improved local control and sphincter preservation.
  • Preoperative CRT also resulted in reduced toxicities compared to postoperative CRT.
  • Overall survival rates were comparable between preoperative and postoperative CRT, with potential for further optimization.

Impact:

  • Findings support the consideration of preoperative CRT as a preferred neoadjuvant approach for locally advanced rectal cancer.
  • Highlights the need for precise diagnostic imaging and optimization of chemotherapy, radiation schedules, and surgical timing.
  • Potential to improve patient outcomes and quality of life in rectal cancer treatment.

Related Experiment Videos